Novartis takes step toward expanding supply of in-demand cancer drug

Novartis is working to expand production of its in-demand prostate cancer drug Pluvicto, announcing Friday it has completed an application to the Food and Drug Administration for approval of a New Jersey factory that manufactures the medicine.